📰 Abt News
Page 192 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
March 26, 2023
Arcblock (ABT) traded 2.3% lower against the U.S. dollar during the 24-hour period ending at 20:00 PM ET on March 25th. One Arcblock token can now be bought for $0.12 or 0.00000439 BTC on popular cryptocurrency exchanges. Arcblock has a market capitalization of $11.89 million and approximately $139,153.89 worth of Arcblock was traded on exchanges […]
March 26, 2023
Beacon Financial Group grew its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 1.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,518 shares of the healthcare product maker’s stock after acquiring an additional 172 shares during the quarter. Beacon […]
March 26, 2023
Beacon Financial Group lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,518 shares of the healthcare product maker’s stock after purchasing an additional 172 shares during the quarter. […]
March 26, 2023
Kingfisher Capital LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 18.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 66,429 shares of the healthcare product maker’s stock after acquiring an additional 10,295 shares during the period. Abbott Laboratories makes up approximately 1.9% of Kingfisher Capital LLC’s holdings, making […]
March 26, 2023
Perfromance Wealth Partners LLC lowered its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 149,368 shares of the healthcare product maker’s stock after selling 2,305 shares during the period. Abbott Laboratories makes up about […]
March 26, 2023
Curbstone Financial Management Corp lowered its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 8.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,228 shares of the healthcare product maker’s stock after selling 2,750 shares during the period. Curbstone Financial Management […]
March 26, 2023
Rothschild Investment Corp IL grew its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 32,983 shares of the healthcare product maker’s stock after buying an additional 482 shares during the quarter. Rothschild Investment Corp IL’s holdings in Abbott Laboratories were worth $3,621,000 […]
March 26, 2023
Polaris Wealth Advisory Group LLC bought a new position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 133,028 shares of the healthcare product maker’s stock, valued at approximately $15,052,000. A number of […]
March 26, 2023
Householder Group Estate & Retirement Specialist LLC trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 14,144 shares of the healthcare product maker’s stock after selling 205 shares during the period. Abbott Laboratories makes […]
March 26, 2023
Seelaus Asset Management LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 3.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,383 shares of the healthcare product maker’s stock after buying an additional 200 shares during […]